Related Experiment Video
Updated: Oct 20, 2025

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation
Published on: April 14, 2016
Expert consensus on clinical management of metabolic bone disease of prematurity (2021)
Chang Yan-Mei1, Lin Xin-Zhu, Zhang Rong
1Department of Pediatrics, Peking University Third Hospital, Beijing 100191 China.
Insights
Metabolic bone disease of prematurity (MBDP) is a bone condition affecting premature infants. This expert consensus provides clinical management guidelines to improve outcomes for affected infants.
Area of Science:
- Neonatology
- Pediatric Endocrinology
- Bone Metabolism
Background:
- Metabolic bone disease of prematurity (MBDP) is a significant concern in neonatology, characterized by reduced bone mineral content due to calcium and phosphorus imbalances.
- Clinical management of MBDP in China lacks systematic research and standardization, leading to varied patient outcomes.
- Understanding and addressing MBDP is crucial for improving the health of premature infants.
Purpose of the Study:
- To establish an expert consensus on the clinical management of MBDP in China.
- To provide evidence-based recommendations for practitioners to standardize care.
- To reduce MBDP incidence and enhance short- and long-term prognoses for affected infants.
Main Methods:
- Utilized the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework.
- Synthesized findings from relevant domestic (China) and international studies.
- Developed expert consensus guidelines based on comprehensive literature review and clinical expertise.
Main Results:
- The consensus provides recommendations covering five key areas: high-risk factors, screening and diagnosis, prevention strategies, treatment protocols, and post-discharge follow-up.
- Specific guidance is offered to address the current irregularities in MBDP clinical management.
- The recommendations aim to standardize care and improve the quality of life for premature infants with MBDP.
Conclusions:
- The developed expert consensus offers a systematic approach to managing MBDP in premature infants.
- Implementation of these guidelines is expected to reduce MBDP incidence and improve patient prognosis.
- This consensus serves as a vital resource for healthcare professionals involved in the care of premature neonates.
Abstract:
Metabolic bone disease of prematurity (MBDP) is a systemic bone disease with a reduction in bone mineral content due to disorder of calcium and phosphorus metabolism. There is still a lack of in-depth research and systematic understanding of MBDP in China, and there are many irregularities in clinical management of this disease. Based on relevant studies in China and overseas, Grading of Recommendations Assessment, Development and Evaluation was used to develop the expert consensus on the clinical management of MBDP, which provides recommendations from the following five aspects: high-risk factors, screening/diagnosis, prevention, treatment, and post-discharge follow-up of MBDP, so as to provide relevant practitioners with recommendations on the clinical management of MBDP to reduce the incidence rate of MBDP and improve its short- and long-term prognosis.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Fractures: Bone Repair
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Standards of Care II
Standards of Care I
Bone Remodeling

